Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,999Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M4,994EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %2.0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XLVKen Fisher 2014-06-30 Add0.01%$55.71 - $61.23
($58.7)
$ 73.7420%Add 34.36%226,412
XLVGeorge Soros 2012-09-30 Sold Out -0.03%$37.27 - $40.3
($38.73)
$ 73.7447%Sold Out0
XLVGeorge Soros 2012-06-30 Buy 0.03%$35.52 - $37.87
($36.91)
$ 73.7450%New holding50,000
XLVKen Fisher 2012-06-30 Add$35.52 - $37.87
($36.91)
$ 73.7450%Add 53.52%119,754
XLVKen Fisher 2011-06-30 Buy 0.01%$33.28 - $36.42
($34.99)
$ 73.7453%New holding86,997
XLVGeorge Soros 2011-03-31 Sold Out $31.5 - $33.18
($32.33)
$ 73.7456%Sold Out0
XLVGeorge Soros 2010-12-31 Reduce-0.15%$30.19 - $31.78
($31.13)
$ 73.7458%Reduce -93.88%34,153
XLVGeorge Soros 2010-09-30 Buy 0.25%$28.03 - $30.68
($29.2)
$ 73.7460%New holding558,053
XLVGeorge Soros 2010-06-30 Sold Out $28.38 - $32.31
($30.13)
$ 73.7459%Sold Out0
XLVGeorge Soros 2010-03-31 Reduce$30.68 - $33
($31.72)
$ 73.7457%Reduce -43.59%6,600
XLVGeorge Soros 2009-12-31 Buy 0.01%$28.07 - $31.62
($30.04)
$ 73.7459%New holding11,700
XLVBill Gates 2009-06-30 Sold Out -4.19%$23.76 - $26.53
($25.04)
$ 73.7466%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XLV is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Barrie, C. TuckerDirector, Senior Officer 2015-04-15Buy4,000$0.05147780view
Orr, Murray RossDirector or Senior Officer of Insider or Subsidiar 2015-04-15Buy11,000$0.04184750view
Masson, Stephen Leo10% Security Holder 2015-04-15Buy5,000$0.04184750view
Van Spankeren, Shawn ArieSenior Officer 2015-04-15Sell10,700$5.651208.67view
Riddell, Clayton H.Director 2015-04-15Sell50,000$43.5369.86view
Riddell, Clayton H.Director 2015-04-15Sell50,000$42.5273.89view
Gorman, John C.Director 2015-04-15Sell984$37.6796.28view
Melbye, Scott EricSenior Officer 2015-04-15Buy5,000$1.445034.72view
Adnani, AmirDirector, Senior Officer 2015-04-15Buy10,000$1.54829.33view
Doucet, RogerDirector 2015-04-15Buy1,000$0.1261516.67view

Press Releases about XLV :

    Quarterly/Annual Reports about XLV:

      News about XLV:

      Articles On GuruFocus.com
      S&P 500 Sector ETFs: A Look Under the Hood, Part 3 Mar 11 2015 
      Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
      Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 


      More From Other Websites
      Maverick Capital Eliminates Its Position in AbbVie Apr 16 2015
      Health Insurance Fee May Reduce UnitedHealth Group’s 1Q15 Margins Apr 16 2015
      What to Expect from UnitedHealth Group’s 1Q15 Earnings Release Apr 16 2015
      How Lucrative Is Mylan’s Acquisition of Perrigo? Apr 16 2015
      Healthcare ETFs in Focus Post JNJ Earnings Beat - ETF News And Commentary Apr 16 2015
      Healthcare Stocks: A Prescription for More Gains? Apr 15 2015
      Curing eye disease, and maybe color blindness Apr 14 2015
      Humana CEO: In agreement with Fink Apr 14 2015
      IBM takes medical data to the cloud Apr 14 2015
      Lone Pine Initiates New Position in HCA Holdings Apr 14 2015
      Remaining Invested and Going Cyclical Apr 13 2015
      Five Positions That Hurt Hedge Funds the Most Last Week Apr 13 2015
      Top trades to go before Thursday's close Apr 09 2015
      Get in shape, earn health discounts Apr 09 2015
      Is the Correction in Healthcare Over? Apr 09 2015
      Best bets this year? Consumer discretionary, health care:... Apr 09 2015
      Top trades to go before the closing bell Apr 08 2015
      Top trades for the 2nd half Apr 08 2015
      U.S. stocks lower as day’s gains fizzle Apr 07 2015
      Sector ETFs And Earnings Apr 07 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK